ArticleEuropean journal of medical research2025
Umbilical cord blood-derived platelet-rich plasma as a coating substrate supporting cell adhesion and biological activities of wound healing.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cord Blood Platelet-Poor Plasma Functionalizes Polycaprolactone Scaffolds for Coupled Vascularization and Osteogenesis in Bone Tissue Engineering.Tissue engineering and regenerative medicine · 2026Article
- Cord Blood-Derived Platelet Gel in Wound Healing: From Biological Rationale to Clinical Application.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair SocietyReview
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlatelet-rich plasma (PrP) is a blood derivative with positive roles in regenerative medicine, particularly in wound healing. Evidence has been reported for using peripheral blood-derived PrP in disease treatments, but umbilical cord blood (UCB)-derived PrP remains limited. Thus, we investigate the roles of UCB-derived PrP in cellular behaviours in vitro and in wound healing in vivo models.
methodsWe used 2D and 3D cell culture models to investigate the role of UCB-derived PrP gels in stimulating the attachment, proliferation, migration, and spheroid formation of umbilical cord-derived mesenchymal stem cell (UCMSC) and human dermal fibroblast (hFB). In addition, immunoassay and PCR were used to understand the enrichment of growth factors in UCB-derived PrP and the change of ECM genes in PrP-treated cells. Finally, a rat model was used to investigate the cutaneous wound healing process.
resultsUCB-derived PrP gels were enriched with platelet-derived growth factor-BB (PDGF-BB) (3394.1 ± 2658.3 pg/mL), vascular endothelial growth factor-A (VEGF-A) (282.0 ± 53.0 pg/mL), hepatocyte growth factor (HFG) (762.7 ± 117.5 pg/mL), and fibroblast growth factor 2 (FGF-2) (17.734 ± 8 pg/mL). In addition, these UCB-derived PrP gels promoted cell attachment (> 154 % and > 117 % for UCMSCs and hFBs, respectively), proliferation (UCMSCs > 121 % and hFBs > 117 % at all time points), migration increased by 27 % and 26 % for UCMSCs and hFBs, and spheroid formation and fusion compared to the control. UCB-derived PrP gels also induced different expression of ECM genes, including COL1, COL3, HAS1, HAS2, HAS3, and ENL, in both UCMSCs and hFBs. Finally, this product from UCBs could enhance the wound healing process in excised skin rat models by reducing the wound area by 80 % compared to 27 % in controls after 14 days.
conclusionsUCB-derived PrP gels facilitate cell behaviours in vitro, including cell adhesion, growth, and migration. In addition, in animal models, UCB-derived PrP reduced the wound healing time and enhanced the completion of skin tissues by increasing granulation tissue formation and reducing neutrophils at wound sites. These UCB-derived PrP gels will be used to support spheroid formation that will be used as biomaterials for 3D printing, engraftment, and wound healing treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.